Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9781800 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2298322 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8816706 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL8584856 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL486955 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL16832270 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2944230 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL7543085 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL2293185 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL11160681 | 1.00 | ZDHHC7 (0.66) | ZDHHC7CA2CA1ABCB1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105742067-A | Production method of aluminum foil for improving capacity extraction rate of solid-state capacitor and improving leakage current | 恒扬（韶关）工业有限公司 | 2016-07-06 | — | — | CN | claimed |
| CN-102280252-B | Method for reducing flow of leakage current of aluminum electrolytic capacitor | ZHAOQING BERYL ELECTRONIC CO LTD | 2014-02-19 | — | — | CN | claimed |
| CN-102280252-A | Method for reducing flow of leakage current of aluminum electrolytic capacitor | — | 2011-12-14 | — | — | CN | claimed |
| US-10781229-B2 | Tris- or neopentyl glycol-based amphiphiles and uses thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2020-09-22 | — | — | US | disclosed |
| US-20190284221-A1 | NOVEL TRIS- OR NEOPENTYL GLYCOL-BASED AMPHIPHILES AND USES THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2019-09-19 | — | — | US | disclosed |
| CN-105742067-A | Production method of aluminum foil for improving capacity extraction rate of solid-state capacitor and improving leakage current | 恒扬（韶关）工业有限公司 | 2016-07-06 | — | — | CN | disclosed |
| CN-102280252-B | Method for reducing flow of leakage current of aluminum electrolytic capacitor | ZHAOQING BERYL ELECTRONIC CO LTD | 2014-02-19 | — | — | CN | disclosed |
| CN-102280252-A | Method for reducing flow of leakage current of aluminum electrolytic capacitor | — | 2011-12-14 | — | — | CN | disclosed |
| EP-0516227-B1 | Dry analytical element for lithium assay | JOHNSON & JOHNSON CLIN DIAG (US) | 1996-07-24 | — | — | EP | disclosed |
| EP-0527983-B1 | NON-IONIC SURFACE ACTIVE COMPOUNDS | KODAK LTD (GB) | 1995-02-01 | — | — | EP | disclosed |
| US-5324450-A | Stable optically active glycidyl ether derivatives | DAISO CO., LTD. (JP) | 1994-06-28 | — | — | US | disclosed |
| EP-0516227-A2 | Dry analytical element for lithium assay | Johnson & Johnson Clinical Diagnostics, Inc. (US) | 1992-12-02 | — | — | EP | disclosed |
| US-5132436-A | Intermediates for making 14-crown-4-ether derivatives | EASTMAN KODAK COMPANY (US) | 1992-07-21 | — | — | US | disclosed |
| US-4973425-A | ELECTROOPTICS | DAISO CO., LTD. (JP) | 1990-11-27 | — | — | US | disclosed |
| US-4909957-A | Containing lactone ring structure | DAISO CO., LTD. (JP) | 1990-03-20 | — | — | US | disclosed |
| EP-0355830-A2 | Liquid crystal composition and use thereof | DAISO CO., LTD. (JP) | 1990-02-28 | — | — | EP | disclosed |
| EP-0306919-A2 | Liquid crystalline compounds and process for production thereof | DAISO CO., LTD. (JP) | 1989-03-15 | — | — | EP | disclosed |
| EP-0019578-B1 | PIPERIDINE DERIVATIVES, PROCESS FOR PREPARING THEM AND POLYMER COMPOSITIONS CONTAINING THEM | Chimosa Chimica Organica S.p.A. (IT) | 1983-03-30 | — | — | EP | disclosed |
| US-4316025-A | STABVILIZERS FOR POLYMERS | CHIMOSA CHIMICA ORGANICA S.P.A. (IT) | 1982-02-16 | — | — | US | disclosed |
| EP-0019578-A1 | Piperidine derivatives, process for preparing them and polymer compositions containing them | Chimosa Chimica Organica S.p.A. (IT) | 1980-11-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284221-A1 | NOVEL TRIS- OR NEOPENTYL GLYCOL-BASED AMPHIPHILES AND USES THEREOF | TGOLN2, GOLIM4, CERT1 | ZDHHC7 785/4885CA2 3551/4885CA1 3561/4885 |
| US-10781229-B2 | Tris- or neopentyl glycol-based amphiphiles and uses thereof | TGOLN2, GOLIM4, CERT1 | ZDHHC7 990/4885CA2 3664/4885CA1 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.